Axis Bioservices Ltd - Company Review
Axis Bioservices Ltd - Company ReviewSummary
Axis Bioservices Ltd (Axis Bioservices), formerly Derrylyn Ltd is a contract research organization that conducts preclinical research services in oncology and angiogenesis. The organization’s wide range of services include drug development services, preclinical studies, sample analysis and bioanalysis. Axis Bioservices’ oncology services include tolerability studies, pharmacokinetic studies, pharmacodyamic and in vitro studies. The organization also offers specialist services such as translational package for identifying the optimal model for preclinical development of the compound; and angiogenic package that uses a combination of in vitro, in vivo and ex vivo techniques for measuring the anti-angiogenic efficacy of the compound. Axis Bioservices is headquartered in Londonderry, the UK.
This comprehensive company report of Axis Bioservices Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.